Stockreport
Two major drug companies are the latest to join TrumpRx [FOX Business Network]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Exclusive: The White House is expecting to announce an expansion of the drugmakers offering discounts on TrumpRx.gov, FOX Business has learned. As early as today, Amgen and GSK will be added to the list of prescription drug manufacturers offering discounts on the government website. That makes a total of 54 prescription medications from six pharmaceutical companies that have signed on to the Most-Favored-Nation pricing under pressure from President Donald Trump and the threat of tariffs. Amgen will offer medication on the website that cuts 80% off the retail price. Amjevita has an original price of $1,484.18, but will be available on TrumpRx.gov for $299. The medication treats rheumatoid arthritis, psoriasis and ulcerative colitis. The company plans to list Aimovig and Repatha as well, for discounts of 62%. GSK will discount Incruse at 55% of the retail price. The drug treats COPD and will be listed at $159.20. GSK also plans to list Annuity, Relenza and Anoro at discounts
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- 4 Biotech Stocks to Watch for Potential Upside in 2026 [Yahoo! Finance][Yahoo! Finance]
- Rapid Micro Biosystems Q4 Earnings Call Highlights [Yahoo! Finance][Yahoo! Finance]
- Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference [Yahoo! Finance][Yahoo! Finance]
- Amgen Inc. (AMGN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha][Seeking Alpha]
- Amgen (AMGN) is now covered by Jefferies Financial Group Inc.. They set a "hold" rating and a $350.00 price target on the stock.[MarketBeat]
- More
AMGN
SEC Filings
SEC Filings
- 3/6/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- AMGN's page on the SEC website
- More